16-31357350-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_000887.5(ITGAX):c.416C>A(p.Pro139Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000568 in 1,602,336 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000887.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGAX | NM_000887.5 | c.416C>A | p.Pro139Gln | missense_variant | 5/30 | ENST00000268296.9 | NP_000878.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGAX | ENST00000268296.9 | c.416C>A | p.Pro139Gln | missense_variant | 5/30 | 1 | NM_000887.5 | ENSP00000268296.5 | ||
ITGAX | ENST00000562522.2 | c.416C>A | p.Pro139Gln | missense_variant | 5/31 | 1 | ENSP00000454623.1 | |||
ITGAX | ENST00000567409.1 | n.634C>A | non_coding_transcript_exon_variant | 4/4 | 1 | |||||
ITGAX | ENST00000562918.5 | c.335C>A | p.Pro112Gln | missense_variant | 5/5 | 2 | ENSP00000483860.1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000927 AC: 21AN: 226430Hom.: 0 AF XY: 0.0000973 AC XY: 12AN XY: 123312
GnomAD4 exome AF: 0.0000586 AC: 85AN: 1450132Hom.: 0 Cov.: 31 AF XY: 0.0000652 AC XY: 47AN XY: 720434
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.416C>A (p.P139Q) alteration is located in exon 5 (coding exon 5) of the ITGAX gene. This alteration results from a C to A substitution at nucleotide position 416, causing the proline (P) at amino acid position 139 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at